🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rationale: Visual hallucinations (VH) are the most common non-motor symptom...
Status
Terminated
Location
Academic Medical Center
Start Date
2013-11
Trial ID
NCT01856738
Treatments Being Tested
Current therapeutic approaches for the treatment of neurodegenerative disea...
Status
Completed
Location
Loghman Hospital
Start Date
2011-01
Trial ID
NCT01696123
Treatments Being Tested
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01399125
This study used two doses of rivastigmine transdermal patch (5 cm\^2, 10 cm...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-09
Trial ID
NCT00549601
This phase IIIb study is intended to implement a consistent treatment way f...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-08
Trial ID
NCT01585272
Treatments Being Tested
The goal of this research study is to evaluate the effectiveness, tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00099216
Treatments Being Tested
This is a bioequivalence study of Rivastigmine 1.5 mg capsules and Exelon A...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT01146067
Treatments Being Tested
The goal of this research study is to evaluate, in the open-label extension...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT00130338
Treatments Being Tested
Auditory hallucinations are among the most distressing aspects of psychotic...
Status
Recruiting
Location
Connecticut Mental Health Center
Start Date
2021-07-15
Trial ID
NCT04366518
Treatments Being Tested